Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a report published on Saturday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance AMPE opened at $0.25 on Friday. Ampio Pharmaceuticals has a 12-month low of $0.18 and a 12-month high of $2.83. The […]

Related Keywords

Colorado ,United States ,Englewood , ,Ampio Pharmaceuticals Price Performance ,Ampio Pharmaceuticals ,Pricet Rowe Associates Inc ,Blackrock Inc ,News Ratings For Ampio Pharmaceuticals Daily ,Hedge Funds Weigh In On Ampio Pharmaceuticals ,Vanguard Group Inc ,Ampio Pharmaceuticals Inc ,Free Report ,Get Free Report ,Street Corp ,Ampio Pharmaceuticals Daily ,Nyseamerican Ampe ,Ampe ,Medical ,03209t10 ,Initiated Coverage ,Stocknews Com ,